Predicting progression of Alzheimer's disease using forward-to-backward bi-directional network with integrative imputation.

Alzheimer’s progression Clinical status prediction MRI biomarker forecasting Missing value imputation Progressive recurrent networks

Journal

Neural networks : the official journal of the International Neural Network Society
ISSN: 1879-2782
Titre abrégé: Neural Netw
Pays: United States
ID NLM: 8805018

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 03 08 2021
revised: 23 02 2022
accepted: 10 03 2022
pubmed: 2 4 2022
medline: 14 4 2022
entrez: 1 4 2022
Statut: ppublish

Résumé

If left untreated, Alzheimer's disease (AD) is a leading cause of slowly progressive dementia. Therefore, it is critical to detect AD to prevent its progression. In this study, we propose a bidirectional progressive recurrent network with imputation (BiPro) that uses longitudinal data, including patient demographics and biomarkers of magnetic resonance imaging (MRI), to forecast clinical diagnoses and phenotypic measurements at multiple timepoints. To compensate for missing observations in the longitudinal data, we use an imputation module to inspect both temporal and multivariate relations associated with the mean and forward relations inherent in the time series data. To encode the imputed information, we define a modification of the long short-term memory (LSTM) cell by using a progressive module to compute the progression score of each biomarker between the given timepoint and the baseline through a negative exponential function. These features are used for the prediction task. The proposed system is an end-to-end deep recurrent network that can accomplish multiple tasks at the same time, including (1) imputing missing values, (2) forecasting phenotypic measurements, and (3) predicting the clinical status of a patient based on longitudinal data. We experimented on 1,335 participants from The Alzheimer's Disease Prediction of Longitudinal Evolution (TADPOLE) challenge cohort. The proposed method achieved a mean area under the receiver-operating characteristic curve (mAUC) of 78% for predicting the clinical status of patients, a mean absolute error (MAE) of 3.5ml for forecasting MRI biomarkers, and an MAE of 6.9ml for missing value imputation. The results confirm that our proposed model outperforms prevalent approaches, and can be used to minimize the progression of Alzheimer's disease.

Identifiants

pubmed: 35364417
pii: S0893-6080(22)00094-6
doi: 10.1016/j.neunet.2022.03.016
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-439

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ngoc-Huynh Ho (NH)

Department of AI Convergence, Chonnam National University, 61186, South Korea. Electronic address: nhho@chonnam.ac.kr.

Hyung-Jeong Yang (HJ)

Department of AI Convergence, Chonnam National University, 61186, South Korea. Electronic address: hjyang@jnu.ac.kr.

Jahae Kim (J)

Department of AI Convergence, Chonnam National University, 61186, South Korea; Department of Nuclear Medicine, Chonnam National University Hospital, 61469, South Korea. Electronic address: jhbt0607@daum.net.

Duy-Phuong Dao (DP)

Department of AI Convergence, Chonnam National University, 61186, South Korea. Electronic address: phuongdd.1997@gmail.com.

Hyuk-Ro Park (HR)

Department of AI Convergence, Chonnam National University, 61186, South Korea. Electronic address: hyukro@jnu.ac.kr.

Sudarshan Pant (S)

Department of AI Convergence, Chonnam National University, 61186, South Korea. Electronic address: sudarshan.pant@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH